A surge in artificial intelligence (AI) breakthroughs has reinvigorated investor excitement in robotics, driving significant venture capital (VC) into US robotics startups. The convergence of AI and advanced robotics is...

Biopharma modalities' venture capital (VC) investments are becoming more selective, favoring proven assets over high-risk innovation. While cardiometabolic drugs and AI-driven drug discovery continue to attract capital, investors are shifting...